Galderma has launched ALASTIN Restorative Eye Complex with TriHex+ in the US, an updated topical formulation targeting visible signs of aging across the upper eyelids, under-eye area and crow’s feet.

Get the latest in Medical Aesthetics in our weekly ValuraNova Pulse. Sign up now.

The formulation combines the company’s TriHex Technology with proprietary Octapeptide-45, alongside ingredients designed to support collagen and elastin production, hydration, skin firmness and elasticity.

In a 12-week clinical evaluation involving 29 participants aged 35–70, investigator assessments showed improvements of 30.13% in crow’s feet fine lines, 33.63% in under-eye puffiness and 21.62% in upper-eyelid fine lines. All three results were statistically significant.

The launch expands ALASTIN’s TriHex+ portfolio, which also includes Regenerating Skin Nectar and Restorative Skin Complex, adding a targeted product for the full periorbital area. The findings are based on a small study, with no control-group or longer-term results disclosed.

Read the full story here.

SOURCEModern Aesthetics
Previous articleLynch Regenerative Medicine secures FDA clearance for Phase 2 trial of regenerative tear trough injectable
Next articleFACTORFIVE introduces DCA-based Renew Dermal Solution